PD-L1 expression is assessed as CPS, which is defined as the ratio of the number of PD-L1-positive tumor cells, lymphocytes, and macrophages to the total number of tumor cells multiplied by 100 [22,23]. This evidence concerns the gene CD274 and neoplasm.